首页 › 基金 › DAFNA Capital Management LLC › ANL

DAFNA Capital Management LLC 对 ANL 的持仓历史

ADLAI NORTYE GROUP LTD · 医疗保健

DAFNA Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 ANL(ADLAI NORTYE GROUP LTD)232,763 股,市值约 US$3.7M,约占其申报组合的 0.80%,在其申报持仓中市值排名第 31 位。 DAFNA Capital Management LLC 最近 2 个申报季度中有 2 个季度披露了 ANL 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)232.76K 股
申报持仓市值$3.72M
组合权重0.80%
首次申报Q2 2026
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

DAFNA Capital Management LLC 对 ANL 的持仓演变

DAFNA Capital Management LLC 于 Q2 2026 首次披露 ANL 持仓:239,553 股(约 US$2.8M)。 该持仓在 Q3 2026 达到峰值 232,763 股,市值约 US$3.7M。 在 2 次申报中,DAFNA Capital Management LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 232,763 股、市值约 US$3.7M,环比减持 -6,790 股。。

逐季持仓明细

季度股数金额变化
Q2 2026 239.55K $2.75M 新进
Q3 2026 232.76K $3.72M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ANL 与 13F 数据

ANL(ADLAI NORTYE GROUP LTD)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 ANL,申报仓位最大的包括:Cormorant Asset Management, LP (US$63.7M), Venrock Adviser, LLC (US$51.4M), MPM BioImpact LLC (US$31.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ANL 的基金

查看 ANL 的全部基金持有人 →

常见问题

How long has DAFNA Capital Management LLC held ANL?

DAFNA Capital Management LLC has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DAFNA Capital Management LLC's current position in ANL?

As of Q3 2026, DAFNA Capital Management LLC holds 232.76K shares of ANL (ADLAI NORTYE GROUP LTD), valued at $3.72M, representing 0.80% of its reported portfolio and ranking #31.

Has DAFNA Capital Management LLC been buying or selling ANL?

In the latest 13F filing (Q3 2026), DAFNA Capital Management LLC reduced its position in ANL. The position peaked in Q3 2026 at 232.76K shares.

Which other funds hold ANL?

Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, MPM BioImpact LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.